Company: TELO
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010298
Chunk: 47

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 1
Chunk 47
---
RE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase
  
    104*
     
    Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    *
    Furnished
    herewith

    ^
    Previously
    filed.

    +
    Denotes
    management contract or compensatory plan or arrangement.

20

SIGNATURES

Pursuant
to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    TELOMIR
    PHARMACEUTICALS, INC.

    Date:
    May 14, 2025
    By:
    /s/
    Erez Aminov

    Erez
    Aminov

    Chief
    Executive Officer & Chairman

    (Principal
    Executive Officer)

    Date:
    May 14, 2025
    By:
    /s/
    Michelle Yanez

    Michelle
    Yanez

    Chief
    Financial Officer, Treasurer and Secretary

    (Principal
    Financial Officer)

21